Travers Smith LLP has acted for Stifel Nicolaus Europe Limited ("Stifel") in its capacity as sole bookrunner and financial adviser on a placing, open offer and offer for subscription of £94 million of Ordinary Shares in Target Healthcare REIT Limited ("Target") (the "Share Issue").
Target is a specialist care home investor listed on the Main Market of the London Stock Exchange, with a current market capitalisation of £366 million.
The Ordinary Shares issued pursuant to the Share Issue were admitted to trading on the Main Market on 27 February 2018.
The Travers Smith team was led by Investment Funds Partner Aaron Stocks and also included Investment Funds Associates Stuart MacKenzie and Laura Le Marechal. US Securities Partner Dan McNamee and Senior Associate Brent Sanders advised Stifel in connection with the marketing of the Share Issue into the US.
Target was advised by Dickson Minto W.S.